172 related articles for article (PubMed ID: 11519037)
1. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages.
Liss C; Fekete MJ; Hasina R; Lam CD; Lingen MW
Int J Cancer; 2001 Sep; 93(6):781-5. PubMed ID: 11519037
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma.
Liss C; Fekete MJ; Hasina R; Lingen MW
Int J Cancer; 2002 Jul; 100(3):283-9. PubMed ID: 12115542
[TBL] [Abstract][Full Text] [Related]
3. Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma.
Eisma RJ; Spiro JD; Kreutzer DL
Laryngoscope; 1999 May; 109(5):687-93. PubMed ID: 10334214
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas.
Benefield J; Petruzzelli GJ; Fowler S; Taitz A; Kalkanis J; Young MR
Invasion Metastasis; 1996; 16(6):291-301. PubMed ID: 9371228
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H
Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
7. [Antiangiogenic and anti-immunosuppressive therapeutic strategies in human head and neck squamous cell carcinoma (HNSCC)].
Strauss L; Volland D; Guerrero A; Reichert T
Mund Kiefer Gesichtschir; 2005 Sep; 9(5):273-81. PubMed ID: 16096774
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
[TBL] [Abstract][Full Text] [Related]
9. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
[TBL] [Abstract][Full Text] [Related]
11. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
[TBL] [Abstract][Full Text] [Related]
12. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas.
Ohta M; Kitadai Y; Tanaka S; Yoshihara M; Yasui W; Mukaida N; Haruma K; Chayama K
Int J Cancer; 2002 Nov; 102(3):220-4. PubMed ID: 12397639
[TBL] [Abstract][Full Text] [Related]
13. Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics.
Fukuiwa T; Takebayashi Y; Akiba S; Matsuzaki T; Hanamure Y; Miyadera K; Yamada Y; Akiyama S
Cancer; 1999 Feb; 85(4):960-9. PubMed ID: 10091776
[TBL] [Abstract][Full Text] [Related]
14. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha.
Torisu H; Ono M; Kiryu H; Furue M; Ohmoto Y; Nakayama J; Nishioka Y; Sone S; Kuwano M
Int J Cancer; 2000 Jan; 85(2):182-8. PubMed ID: 10629075
[TBL] [Abstract][Full Text] [Related]
15. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.
Ninck S; Reisser C; Dyckhoff G; Helmke B; Bauer H; Herold-Mende C
Int J Cancer; 2003 Aug; 106(1):34-44. PubMed ID: 12794754
[TBL] [Abstract][Full Text] [Related]
16. Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells: predominance of vascular endothelial growth factor.
Campbell CL; Savarese DM; Quesenberry PJ; Savarese TM
Int J Cancer; 1999 Mar; 80(6):868-74. PubMed ID: 10074920
[TBL] [Abstract][Full Text] [Related]
17. Modulation of endothelial cell network formation in vitro by molecular signaling of head and neck squamous cell carcinoma (HNSCC) exposed to cetuximab.
Jouan-Hureaux V; Boura C; Merlin JL; Faivre B
Microvasc Res; 2012 Mar; 83(2):131-7. PubMed ID: 21820450
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications.
Hasina R; Whipple ME; Martin LE; Kuo WP; Ohno-Machado L; Lingen MW
Lab Invest; 2008 Apr; 88(4):342-53. PubMed ID: 18283272
[TBL] [Abstract][Full Text] [Related]
19. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
Bran B; Bran G; Hörmann K; Riedel F
Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma.
Lingen MW; Polverini PJ; Bouck NP
Cancer Res; 1998 Dec; 58(23):5551-8. PubMed ID: 9850093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
